Click here to read the supplement.
Historically, multiple sclerosis (MS) has not been commonly studied in minority populations. However, important challenges must be overcome to provide optimal MS treatment in this patient population. In this supplement from Neurology Reviews , Dr. Castro-Borrero discusses MS in African Americans and Hispanic Americans, including:
- Incidence, age of onset, and disease progression
- Barriers to optimal treatment
- Recommendations for improved MS management
About the Author
Wanda Castro-Borrero, MD
Director, US Medical MS Franchise
& MS UP (underserved populations) Lead
Biogen